Effect of Venglustat in Patients With Renal Impairment
Status:
Completed
Trial end date:
2019-02-27
Target enrollment:
Participant gender:
Summary
Primary Objective:
To study the effect of mild, moderate and severe renal impairment on the pharmacokinetics
(PK) of Venglustat following a single dose.
Secondary Objective:
To assess the tolerability of Venglustat given as a single dose in subjects with mild,
moderate and severe renal impairment in comparison with matched subjects with normal renal
function.